TherapeuticsMD, Inc.
NMS: TXMDLive Quote
📈 ZcoreAI Score
Our AI model analyzes TherapeuticsMD, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get TXMD Z-Score →About TherapeuticsMD, Inc.
Healthcare
Drug Manufacturers - Specialty & Generic
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
📊 Fundamental Analysis
TherapeuticsMD, Inc. demonstrates a profit margin of -18.8%, which is below the sector average, suggesting competitive pressure.
The company recently reported 33.9% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -2.4%, which indicates that capital utilization is currently under pressure.
At a current price of $2.07, TXMD currently sits at the 56th percentile of its 52-week range (Range: $0.93 - $2.95).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$23.96M
Trailing P/E
--
Forward P/E
5.91
Beta (5Y)
0.56
52W High
$2.95
52W Low
$0.93
Avg Volume
52K
Day High
Day Low